Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.375
-0.015 (-1.08%)
At close: Jun 2, 2026, 4:00 PM EDT
1.370
-0.005 (-0.36%)
After-hours: Jun 2, 2026, 4:10 PM EDT
Biomea Fusion Employees
Biomea Fusion had 41 employees as of December 31, 2025. The number of employees decreased by 65 or -61.32% compared to the previous year.
Employees
41
Change
-65
Growth
-61.32%
Revenue / Employee
n/a
Profits / Employee
-$1,096,341
Market Cap
99.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -65 | -61.32% |
| Sep 30, 2025 | 42 | -65 | -60.75% |
| Jun 30, 2025 | 63 | -49 | -43.75% |
| Mar 31, 2025 | 79 | -31 | -28.18% |
| Dec 31, 2024 | 106 | 3 | 2.91% |
| Sep 30, 2024 | 107 | 4 | 3.88% |
| Jun 30, 2024 | 112 | 18 | 19.15% |
| Mar 31, 2024 | 110 | 24 | 27.91% |
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Sep 30, 2023 | 103 | 28 | 37.33% |
| Jun 30, 2023 | 94 | 22 | 30.56% |
| Mar 31, 2023 | 86 | 29 | 50.88% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Sep 30, 2022 | 75 | 28 | 59.57% |
| Jun 30, 2022 | 72 | 52 | 260.00% |
| Mar 31, 2022 | 57 | 37 | 185.00% |
| Dec 31, 2021 | 51 | 39 | 325.00% |
| Sep 30, 2021 | 47 | 35 | 291.67% |
| Jun 30, 2021 | 20 | - | - |
| Mar 31, 2021 | 20 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Verrica Pharmaceuticals | 76 |
| PolyPid | 75 |
| PepGen | 56 |
| Cardiff Oncology | 31 |
| Outlook Therapeutics | 17 |
BMEA News
- 14 days ago - Biomea Fusion Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 21 days ago - Biomea Fusion to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - Biomea Fusion reports Q1 EPS (17c), consensus (19c) - TheFly
- 21 days ago - Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 22 days ago - Biomea Fusion Quarterly report: Q1 2026 - Filings
- 22 days ago - Biomea Fusion Earnings release: Q1 2026 - Filings
- 27 days ago - Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions - GlobeNewsWire
- 4 weeks ago - Biomea Fusion Transcript: Status update - Transcripts